BioInvent receives Investigational New Drug approval for monoclonal antibody BI-1910
BI-1910 is now the second of the company’s anti-tumour necrosis factor receptor 2 programmes to enter clinical development
Read More
Tag: monoclonal antibody
UK approves monoclonal antibody treatment for COVID-19
Regeneron/Roche’s drug found to reduce hospitalisation
Read More
GSK, Vir Biotech seek emergency use authorisation for COVID-19 antibody
Companies are requesting emergency approval of drug for the early treatment of COVID-19
Read More
GSK launches late-stage study of long-acting antibody for severe asthma
GSK’294 is designed to deliver long-acting suppression of IL-5 in severe eosinophilic asthma patients
Read More
GSK’s COVID-19 antibody shows potential in older patients
Investigational treatment did not show statistical significance in all age groups
Read More
FDA approves Sarclisa for relapsed refractory multiple myeloma
The approval of the monoclonal antibody “provides a new treatment option for patients whose disease has returned or become resistant to their prior treatments.”
Read More
European approval for AbbVie’s Skyrizi
The approval is for the treatment of moderate to severe plaque psoriasis.
Read More
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
- NHS reduces long waits for cancer care and achieves faster ambulance responses
- MHRA’s AI Airlock to address challenges for regulating AI medical devices
